Panacea Biotec Limited (NSE:PANACEABIO)
India · Delayed Price · Currency is INR 399.90
+11.25 (2.89%)
Sep 11, 2026, 3:29 PM IST
Panacea Biotec Market Cap
Panacea Biotec has a market cap or net worth of 24.36 billion as of September 14, 2026. Its market cap has decreased by -6.70% in one year.
Market Cap
24.36B
Enterprise Value
23.79B
Revenue
6.73B
Ranking
n/a
PE Ratio
n/a
Stock Price
399.90
ChartMarket Cap Chart
Since April 1, 2002, Panacea Biotec's market cap has increased from 21.08B to 24.36B, an increase of 15.57%. That is a compound annual growth rate of 0.59%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 24.36B | 5.67% |
| Dec 31, 2025 | 23.05B | -10.11% |
| Dec 31, 2024 | 25.64B | 149.32% |
| Dec 29, 2023 | 10.28B | 18.20% |
| Dec 30, 2022 | 8.70B | -28.49% |
| Dec 31, 2021 | 12.17B | -17.07% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Biocon | 632.66B |
| Anthem Biosciences | 529.91B |
| OneSource Specialty Pharma | 182.54B |
| Concord Biotech | 157.52B |
| Blue Jet Healthcare | 107.61B |
| Supriya Lifescience | 72.58B |
| Zota Health Care | 37.65B |
| Dishman Carbogen Amcis | 26.22B |